EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Chronic Lymphocytic Leukaemia as a Disease of Time: A Four‐Clock Framework for Therapeutic Stewardship

Fortunato Morabito iD, Enrica Antonia Martino iD, Ernesto Vigna, Massimo Gentile iD

European Journal of Haematology · 16.11.2026

DOI: 10.1111/ejh.70360 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Haematology, online erschienen am 16.11.2026. Verfasst von Fortunato Morabito und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dafne Srl, Reggio Calabria, Italy. Die Arbeit nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic lymphocytic leukaemia (CLL) is defined not only by disease biology but also by time. Its natural history reflects the pace of clonal evolution, the changing reserve of host immunity, the ordered use of therapeutic classes and the time patients seek to preserve outside illness and treatment. The expansion of highly active targeted therapies has shifted the clinical challenge from selecting an effective regimen to managing a longitudinal therapeutic trajectory. We propose a four‐clock framework for CLL care. The clonal clock captures evolutionary tempo and biological urgency; the immune clock captures host immune reserve and recoverability; the therapeutic clock captures treatment exposure, resistance and preservation of future options; and the human clock captures patient‐valued time, treatment burden and tolerance for uncertainty. Discordance among these clocks may be more informative than any single baseline risk factor. Therapeutic stewardship aims to align treatment intensity, duration, sequencing, monitoring and supportive care with the clock driving risk at each transition while minimising avoidable harm to the others. This framework is not a validated score or a substitute for guidelines, but an integrative clinical reasoning model that makes discordance among established domains explicit and supports their repeated reassessment at clinically meaningful transitions. Its proposed educational and clinical utility requires prospective evaluation.

Schlagwörter

Stichwörter der Autor:innen

chronic lymphocytic leukaemiafrailtymeasurable residual diseasepatient‐centred caretherapeutic stewardshiptreatment sequencing

Autor:innen und Institutionen

  • Dafne Srl, Reggio Calabria, Italy.
  • Hematology Unit, Department of Onco-Hematology, AO of Cosenza, Cosenza, Italy.
  • Department of Pharmacy, Health and Nutritional Science, University of Calabria, Rende, Italy.

ORCID-Profile: Fortunato Morabito, Enrica Antonia Martino, Massimo Gentile

Zitieren

APA

Morabito, F., Martino, E. A., Vigna, E., & Gentile, M. (2026). Chronic Lymphocytic Leukaemia as a Disease of Time: A Four‐Clock Framework for Therapeutic Stewardship. European Journal of Haematology. https://doi.org/10.1111/ejh.70360

Vancouver

Morabito F, Martino EA, Vigna E, Gentile M. Chronic Lymphocytic Leukaemia as a Disease of Time: A Four‐Clock Framework for Therapeutic Stewardship. European Journal of Haematology. 2026. doi:10.1111/ejh.70360

BibTeX
@article{Morabito2026,
  author = {Morabito, Fortunato and Martino, Enrica Antonia and Vigna, Ernesto and Gentile, Massimo},
  title = {Chronic Lymphocytic Leukaemia as a Disease of Time: A Four‐Clock Framework for Therapeutic Stewardship},
  journal = {European Journal of Haematology},
  year = {2026},
  doi = {10.1111/ejh.70360}
}
Kostenlos starten →